Mixed hemorrhoids
Conditions
Interventions
Bupivacaine Liposome Group:266 mg of bupivacaine liposome injection in 20 ml is divided into 6 equal doses, with 3 ml administered per injection site, for a total of 18 ml.
Sponsors
Sichuan University, West China Hospital
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Patients suitable for hemorrhoid surgery. 2. The preoperative ASA classification was grade I to III; 3. Age: 15-75 years old Gender is not limited. 4.BMI is 18 to 28 kg/m^2; 5. Complete medical records; 6. Both the patient and their family members were aware of this study. The patient voluntarily participated in this experiment and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Allergic to the drugs used in this research, as well as local anesthetic drugs or opioids; 2. Suffering from severe heart diseases (unstable angina pectoris, myocardial infarction within the last 3 months, etc.), severe liver and kidney dysfunction, and coagulation dysfunction; 3. Receive analgesic drug treatment 24 hours before the operation; 4. Undergo various surgical operations; 5. Long-term history of opioid use or drug abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum inflammatory marker levels;Assessment of early bowel function recovery;Recovery of sphincter function;QOR-15 questionnaire;Wound healing status;Complete postoperative pain resolution;Adverse reactions; | — |
Countries
China
Contacts
Public ContactHanlin Gong
Sichuan University, West China Hospital
Outcome results
None listed